BBOX1 promotes triple-negative breast cancer progression by controlling IP3R3 stability

被引：4
|
作者：
Liao, Chengheng [1 ]
Zhang, Qing [1 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA
来源：
MOLECULAR & CELLULAR ONCOLOGY | 2020年 / 7卷 / 06期
关键词：
TNBC; 2-OG dependent enzyme; therapeutic target;
D O I：
10.1080/23723556.2020.1813526
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Limited therapeutic options impede the clinical outcome of triple-negative breast cancer (TNBC). Our recent study uncovered a novel signaling pathway implicating gamma-butyrobetaine hydroxylase 1 (BBOX1) in the control of cell growth in TNBC, via inositol 1, 4, 5-trisphosphate receptor type 3 (IP3R3) mediated calcium signaling which is essential for cellular energy metabolism.
引用
收藏
页数：3
相关论文
共 50 条
  • [21] MicroRNAs in regulation of triple-negative breast cancer progression
    Dominika Piasecka
    Marcin Braun
    Radzislaw Kordek
    Rafal Sadej
    Hanna Romanska
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 1401 - 1411
  • [22] MicroRNAs in regulation of triple-negative breast cancer progression
    Piasecka, Dominika
    Braun, Marcin
    Kordek, Radzislaw
    Sadej, Rafal
    Romanska, Hanna
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (08) : 1401 - 1411
  • [23] SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1
    Deng, Ling
    Liao, Li
    Zhang, Yin-Ling
    Yang, Shao-Ying
    Hu, Shu-Yuan
    Andriani, Lisa
    Ling, Yun-Xiao
    Ma, Xiao-Yan
    Zhang, Fang-Lin
    Shao, Zhi-Ming
    Li, Da-Qiang
    SCIENCE ADVANCES, 2024, 10 (14)
  • [24] MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2
    Liu, Heng
    Wang, Gangyue
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (03)
  • [25] Claudin 1, 3, 4, and 7 expression in triple-negative breast cancer
    Ko, Beom Seok
    Kim, Hee Jeong
    Yu, Jong Han
    Lee, Jong Won
    Sohn, Byung Ho
    Kim, Sung-Bae
    Gong, Gyungyub
    Ahn, Sei-Hyun
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] USP10 promotes the progression of triple-negative breast cancer by enhancing the stability of TCF4 protein
    Yang, Jing-ru
    Lu, Yong-bin
    Su, Hong-xin
    Xiao, Yi
    Pan, Qing
    Su, Fei
    Zhang, Xiao-bin
    Zhu, Kai-li
    Guan, Quan-lin
    Ling, Xiao-ling
    BIOCHEMICAL PHARMACOLOGY, 2023, 218
  • [27] Serglycin proteoglycan promotes progression and metastasis of triple-negative breast cancers
    Johnstone, Cameron N.
    Harris, Nathaniel
    Ranson, Marie
    Rustgi, Anil K.
    Anderson, Robin L.
    CANCER RESEARCH, 2015, 75
  • [28] The oncogenic miR-429 promotes triple-negative breast cancer progression by degrading DLC1
    Li, Yao
    Meng, Xue
    Luo, Yuqing
    Luo, Shuai
    Li, Jin
    Zeng, Jiafei
    Huang, Xiang
    Wang, Jinjing
    AGING-US, 2023, 15 (18): : 9809 - 9821
  • [29] CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1
    Lin, Yuxiang
    Zhang, Jie
    Li, Yan
    Guo, Wenhui
    Chen, Lili
    Chen, Minyan
    Chen, Xiaobin
    Zhang, Wenzhe
    Jin, Xuan
    Jiang, Meichen
    Xiao, Han
    Wang, Chuan
    Song, Chuangui
    Fu, Fangmeng
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [30] LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1
    Parmanand Malvi
    Radoslav Janostiak
    Suresh Chava
    Padmini Manrai
    Esther Yoon
    Kamaljeet Singh
    Malini Harigopal
    Romi Gupta
    Narendra Wajapeyee
    Oncogenesis, 9
12345